New findings suggest that inhibiting nuclear factor-κB (NF-κB) inducing kinase (NIK) could be as therapeutically efficacious as blocking B cell activating factor (BAFF; also known as TNF ligand ...

He says in the two years since the foundational pre-clinical work was completed, the team has shown that it's feasible to manufacture BAFF CAR T-cells for human subjects. The innovation is ...